Anti-FAS/ FASN/ OA-519 monoclonal antibody

Anti-FAS/ FASN/ OA-519 antibody for FACS & in-vivo assay

Target products collectionGo to FASN/FASN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T16514-Ab-1/ GM-Tg-hg-T16514-Ab-2Anti-Human FASN monoclonal antibodyHuman
GM-Tg-rg-T16514-Ab-1/ GM-Tg-rg-T16514-Ab-2Anti-Rat FASN monoclonal antibodyRat
GM-Tg-mg-T16514-Ab-1/ GM-Tg-mg-T16514-Ab-2Anti-Mouse FASN monoclonal antibodyMouse
GM-Tg-cynog-T16514-Ab-1/ GM-Tg-cynog-T16514-Ab-2Anti-Cynomolgus/ Rhesus macaque FASN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T16514-Ab-1/ GM-Tg-felg-T16514-Ab-2Anti-Feline FASN monoclonal antibodyFeline
GM-Tg-cang-T16514-Ab-1/ GM-Tg-cang-T16514-Ab-2Anti-Canine FASN monoclonal antibodyCanine
GM-Tg-bovg-T16514-Ab-1/ GM-Tg-bovg-T16514-Ab-2Anti-Bovine FASN monoclonal antibodyBovine
GM-Tg-equg-T16514-Ab-1/ GM-Tg-equg-T16514-Ab-2Anti-Equine FASN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T16514-Ab-1/ GM-Tg-hg-T16514-Ab-2; GM-Tg-rg-T16514-Ab-1/ GM-Tg-rg-T16514-Ab-2;
GM-Tg-mg-T16514-Ab-1/ GM-Tg-mg-T16514-Ab-2; GM-Tg-cynog-T16514-Ab-1/ GM-Tg-cynog-T16514-Ab-2;
GM-Tg-felg-T16514-Ab-1/ GM-Tg-felg-T16514-Ab-2; GM-Tg-cang-T16514-Ab-1/ GM-Tg-cang-T16514-Ab-2;
GM-Tg-bovg-T16514-Ab-1/ GM-Tg-bovg-T16514-Ab-2; GM-Tg-equg-T16514-Ab-1/ GM-Tg-equg-T16514-Ab-2
Products NameAnti-FASN monoclonal antibody
Formatmab
Target NameFASN
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FASN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FAS/ FASN/ OA-519 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T16514
    Target NameFASN
    Gene ID2194,14104,50671,715708,483378,100270775,281152,100057311
    Gene Symbol and SynonymsA630082H08Rik,FAS,FASN,OA-519,SDR27X1
    Uniprot AccessionP49327,P12785,Q71SP7
    Uniprot Entry NameFAS_HUMAN,FAS_RAT,FAS_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000169710
    Target ClassificationTumor-associated antigen (TAA)

    The target: FASN, gene name: FASN, also named as FAS, OA-519, SDR27X1. The enzyme encoded by this gene is a multifunctional protein. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-alpha. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.